Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment. | Indian J Hematol Blood Transfus | 2022 | 36258734 | PubTator, text mining | PubMed |
| Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV. | Front Genet | 2022 | 36246609 | PubTator, text mining | PubMed |
| Metallo-Drugs in Cancer Therapy: Past, Present and Future. | Molecules | 2022 | 36235023 | PubTator, text mining | PubMed |
| Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis. | Int J Mol Sci | 2022 | 36233193 | PubTator, text mining | PubMed |
| Obligatory Role of AMPK Activation and Antioxidant Defense Pathway in the Regulatory Effects of Metformin on Cellular Protection and Prevention of Lens Opacity. | Cells | 2022 | 36230981 | PubTator, text mining | PubMed |
| Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response. | Cancers (Basel) | 2022 | 36230710 | PubTator, text mining | PubMed |
| Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 36230695 | PubTator, text mining | PubMed |
| Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. | Ther Adv Endocrinol Metab | 2022 | 36225721 | PubTator, text mining | PubMed |
| Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology. | Clin Pharmacokinet | 2022 | 36219340 | PubTator, text mining | PubMed |
| Potential methylation-regulated genes and pathways in hepatocellular neoplasm, not otherwise specified. | Front Oncol | 2022 | 36212481 | PubTator, text mining | PubMed |
| Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. | Front Oncol | 2022 | 36212403 | PubTator, text mining | PubMed |
| Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes. | Front Pharmacol | 2022 | 36210832 | PubTator, text mining | PubMed |
| Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters. | Curr Ther Res Clin Exp | 2022 | 36188630 | PubTator, text mining | PubMed |
| Mutation in Transmembrane Domain 8 of Human Urate Transporter 1 Disrupts Uric Acid Recognition and Transport. | ACS Omega | 2022 | 36188325 | PubTator, text mining | PubMed |
| Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials. | Front Endocrinol (Lausanne) | 2022 | 36187122 | PubTator, text mining | PubMed |
| Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3. | Front Physiol | 2022 | 36160869 | PubTator, text mining | PubMed |
| Literature review of the clinical characteristics of metformin-induced hepatotoxicity. | Front Pharmacol | 2022 | 36147344 | PubTator, text mining | PubMed |
| Comprehensive Study of Antiretroviral Drug Permeability at the Cervicovaginal Mucosa via an In Vitro Model. | Pharmaceutics | 2022 | 36145684 | PubTator, text mining | PubMed |
| Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions. | Pharmaceuticals (Basel) | 2022 | 36145347 | PubTator, text mining | PubMed |
| The Future of Pharmacogenomics Requires New Discoveries and Innovative Education. | Genes (Basel) | 2022 | 36140743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=26